See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Inflammation

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10976 10-HDA New 14113-05-4 ≥98% 2011-10-13 2.886165015296 10-hda fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen 2.886165015296
10008128 10(S),17(S)-DiHDoHE Exclusive 871826-47-0 ≥98% ✓ 2007-08-21 140.695911602210 10-s-17-s-dihdohe PDX; Protectin DX inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 10(s), 17(s)-dihdohe protectin-dx protectindx 140.695911602210
20140 12-oxo Leukotriene B4 136696-10-1 ≥95% 2009-03-06 28.991591160220 12-oxo-leukotriene-b4 12-keto LTB4; 12-oxo LTB4 LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 28.991591160220
34560 12(R)-HETE 82337-46-0 ≥98% 37.718508287292 12-r-hete hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases 37.718508287292
10007247 12(R)-HETE Lipid Maps MS Standard 82337-46-0 ≥98% 2009-02-17 20.815497237568 12-r-hete-lipid-maps-ms-standard hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards 20.815497237568
10010425 13,14-dihydro-15-keto Prostaglandin D1 Exclusive - >98% ✓ 2008-05-09 0.494944751381 13-14-dihydro-15-keto-prostaglandin-d1 13,14-dihydro-15-keto PGD1 PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways 0.494944751381
13100 13,14-dihydro-15-keto-tetranor Prostaglandin D2 Exclusive - ≥95% ✓ 2009-10-28 70.577546961326 13-14-dihydro-15-keto-tetranor-prostaglandin-d2 PGDM metabolites PGD2 CRTH2 DP2 tetranors agonists prostaglandins receptors CRTH2/DP2 70.577546961326
13101 13,14-dihydro-15-keto-tetranor Prostaglandin E2 Exclusive 20675-85-8 ≥95% ✓ 2009-10-23 22.652292817679 13-14-dihydro-15-keto-tetranor-prostaglandin-e2 PGEM metabolites 13,14-dihydro-15-keto PGE2 CRTH2 PGs tetranorPGEM tetranor-PGEM 22.652292817679
20150 14,15-dehydro Leukotriene B4 114616-11-4 >97% 2008-06-02 39.686839779005 14-15-dehydro-leukotriene-b4 14,15-dehydro LTB4 leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition 39.686839779005
10009286 (±)14(15)-EET-SI 218461-97-3 ≥95% 2007-05-14 15.116151012891 -14-15-eet-si (±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF 15.116151012891
10011360 14,15-Leukotriene C4 75290-60-7 >95% 2008-05-23 26.676279926335 14-15-leukotriene-c4 EXC4; Eoxin C4; 14,15-LTC4 leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory 26.676279926335
10011362 14,15-Leukotriene E4 1000852-57-2 ≥97% 2008-11-15 52.620694554064 14-15-leukotriene-e4 14,15-LTE4; EXE4; Eoxin E4 leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes 52.620694554064
10011677 15-Lipoxygenase-1 Western Ready Control Exclusive - Whole cell lysate ✓ 2008-06-17 19.012048448788 15-lipoxygenase-1-western-ready-control 15-LOX-1 Western Ready Control; 15-LO-1 Western Ready Control proteins 15LO1 lipoxygenases 15(S)-HETE 13(S)-HODE 15S-HETE 13S-HODE interleukins western blots WBs immunoblotting blotting 19.012048448788
10011263 15-Lipoxygenase-2 (human recombinant) - >95% 2008-03-25 46.314229588705 15-lipoxygenase-2-human-recombinant 15-LO-2; 15-LOX-2 arachidonic acids recombinant proteins 15-HETE 15-HpETE 46.314229588705
10010468 15-Lipoxygenase Inhibitor 1 Exclusive 928853-86-5 ≥98% ✓ 2008-10-23 39.314433220636 15-lipoxygenase-inhibitor-1 15-LO Inhibitor 1 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants 39.314433220636
10174 16(17)-EpDPE - ≥90% 2004-01-14 24.917596685082 16-17-epdpe 16,17-epoxy Docosapentaenoic Acid; 16,17 EDP epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP 24.917596685082
13532 17-phenyl trinor Prostaglandin E2 ethyl amide Exclusive - ≥98% ✓ 2010-05-04 395.592817679557 17-phenyl-trinor-prostaglandin-e2-ethyl-amide 17-phenyl trinor PGE2 ethyl amide 17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs 395.592817679557
10005099 17(R)-HDoHE Exclusive 155976-53-7 ≥98% ✓ 2005-01-05 24.270205209155 17-r-hdohe 17(R)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 24.270205209155
13060 17(R)-Resolvin D1 Exclusive 528583-91-7 ≥95% ✓ 2008-12-18 141.253393133083 17-r-resolvin-d1 AT-RvD1; Aspirin-triggered-Resolvin D1; 17(R)-RvD1 EPAs DHAs resolvins inflammation antiinflammatory anti-inflammatory immune response aspirin LOXs 17R ATRvD1 17RRvD1 141.253393133083
10009799 17(S)-HDoHE - ≥98% 2007-03-12 10.232854511970 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 10.232854511970
13185 17(S)-HpDoHE - ≥98% 2009-07-02 5.747817679557 17-s-hpdohe 17(S)-hydroperoxy Docosahexaenoic Acid inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα 17(s)-hpdohe 17s-hdohe 5.747817679557
20170 18-carboxy dinor Leukotriene B4 102674-12-4 ≥97% 2009-02-24 207.554176795580 18-carboxy-dinor-leukotriene-b4 18-carboxy dinor LTB4 LTs leukotrienes metabolism β-oxidation β oxidation liver LTBs 207.554176795580
10175 19(20)-EpDPE - ≥98% 2004-01-14 34.789093922651 19-20-epdpe 19,20-epoxy Docosapentaenoic Acid; 19,20 EDP metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP 34.789093922651
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - 99% deuterated product ✓ 2009-07-24 14.387154696133 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 14.387154696133
10006330 2,3-dinor Thromboxane B1 - >98% 2005-03-02 88.317103393843 2-3-dinor-thromboxane-b1 2,3-dinor TXB1 metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits 88.317103393843
9000683 25-hydroxy Vitamin D3 New 19356-17-3 ≥98% 2012-01-12 69.944444444444 25-hydroxy-vitamin-d3 RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol 25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum 69.944444444444
13222 2-Acetyl-5-tetrahydroxybutyl Imidazole 94944-70-4 ≥95% 2009-10-08 58.696187845304 2-acetyl-5-tetrahydroxybutyl-imidazole THI; 2-ATHBI; 2-Acetyl-4-tetrahydroxybutyl Imidazole sphingosines-1-phosphates S1P lyases S1PL inhibitors lymphatic tissues lymphocytes egress thymus lymphoid organs lymphopenia immunosuppression 58.696187845304
10007980 3,4-DAA - ≥95% 2006-08-09 3.768259668508 3-4-daa Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines 3.768259668508
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 2.289024419063 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.289024419063
9000785 3-Deazaadenosine 6736-58-9 ≥98% 2011-06-14 0.693370165745 3-deazaadenosine c3Ado; deaza-Ado; DZA S-adenosylhomocysteine hydrolases homocysteine S-adenosylmethionine methyltransferases inhibitors SAH anti-inflammatory NF-κB NF κB NF kB anti-viral anti-bacterial inflammation infectious diseases leukocytes chemotaxis lymphocyte-mediated cytolysis phagocytosis degranulation signaling 3-DZA ado inhibits inhibition SAM 0.693370165745
10008445 3-methoxy Limaprost - >98% 2006-05-25 34.762209944751 3-methoxy-limaprost 3-methoxy-2,3-dihydro-Limaprost; 3-methoxy-17α,20-dimethyl-Δ2-Prostaglandin E1 PGE1 prostaglandins platelets aggregation inhibits inhibitors inhibition analog ADP collagen-induced adhesiveness 34.762209944751
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 121.635972989564 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 121.635972989564
10007820 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody - 2006-09-13 7.691938724259 5-lipoxygenase-phospho-ser523-polyclonal-antibody 5-LO (Phospho-Ser523) Polyclonal Antibody wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting 7.691938724259
10006618 5-OxoETE Receptor Blocking Peptide - 2005-03-07 0E-12 5-oxoete-receptor-blocking-peptide TG1019; R527 antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty 0E-12
100025 5-OxoETE Receptor Polyclonal Antibody - 2004-12-14 207.212596685083 5-oxoete-receptor-polyclonal-antibody TG1019; R527 WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting 207.212596685083
90420 5(S),14(R)-Lipoxin B4 98049-69-5 >95% 2008-11-17 45.002811540823 5-s-14-r-lipoxin-b4 5(S),14(R)-LXB4 LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors 45.002811540823
90415 5(S),6(R),15(R)-Lipoxin A4 171030-11-8 ≥95% 2008-11-17 86.651298342541 5-s-6-r-15-r-lipoxin-a4 5(S),6(R),15(R)-LXA4; AT-Lipoxin A4; 15-epi Lipoxin A4 inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered 86.651298342541
10005032 5(S),6(R)-7-trihydroxymethyl Heptanoate - ≥95% 2007-06-13 108.264972375691 5-s-6-r-7-trihydroxymethyl-heptanoate BML-111 lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear 108.264972375691
10009999 5(Z),11(Z),14(Z)-Eicosatrienoic Acid 7019-85-4 ≥98% 2007-08-08 2.323011049724 5-z-11-z-14-z-eicosatrienoic-acid Sciadonic Acid; 5,11,14,20:3 inflammation PUFA fatty acids MPSO maritime pine seed oil Pinus pinaster inflammatory (5z,8z,11z)-eicosa-5,8,11-trienoic acid 2.323011049724
10010484 5(Z),14(Z)-Eicosadienoic Acid Exclusive 122055-58-7 ≥98% ✓ 2008-11-21 18.316146408840 5-z-14-z-eicosadienoic-acid fatty acids polyunsaturated PUFAs 18.316146408840
10878 7(R)-Maresin 1 New 1268720-28-0 ≥95% 2012-02-01 204.905314917127 7-r-maresin-1 7(R)-MaR1 docosahexaenoic acids DHA macrophages zymosan inflammation phagocytosis fatty brain retina murine peritonitis FITC 7(R) maresin 1 mar 1 204.905314917127
10546 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid Exclusive 887752-13-8 ≥98% ✓ 2010-10-22 4.819226519337 7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid 7(S),17(S)-hydroxy DPA opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids 4.819226519337
13161 7(S)-Maresin 1 Exclusive 1268720-66-6 ≥95% ✓ 2010-08-19 88.116926167754 7-s-maresin-1 7(S)-MaR1 docosahexaenoic acids DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 inflammation antiinflammatory anti-inflammation antiinflammation Docosahexaenoic Acid 88.116926167754
13655 Adapalene 106685-40-9 ≥98% 2010-09-10 4.705864463481 adapalene Differin; CD 271 agonists retinoic acids differentiation anti-inflammatory inflammation antiinflammatory anti inflammatory RARs RAR-β RARβ β RAR-b RARb RARbeta RAR-beta RAR-.beta. RAR.beta. RAR-γ RARγ RARg RAR-g RARgamma RAR-gamma RAR.gamma. RAR-.gamma. CD-271 CD271 Naphthalenes 4.705864463481
13297 AG-126 118409-62-4 ≥95% 2009-07-14 6.085153906866 ag-126 Tyrphostin AG-126 tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation 6.085153906866
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 56.043558011050 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 56.043558011050
10010241 AICAR 2627-69-2 >98% 2008-02-25 141.414828729282 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 141.414828729282
10010332 AMP-Deoxynojirimycin Exclusive 216758-20-2 ≥95% ✓ 2008-11-21 28.911821158175 amp-deoxynojirimycin Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells 28.911821158175
13144 Anacardic Acid 16611-84-0 ≥98% 2010-02-12 3.763515709289 anacardic-acid 6-pentadecyl Salicylic Acid HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 3.763515709289
11001 Anatabine New 2743-90-0 ≥95% 2011-11-10 0.311827956989 anatabine alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells 0.311827956989
500830 Anti-Ovalbumin IgG1 (mouse) EIA Kit New - 2011-11-21 32.159345101738 anti-ovalbumin-igg1-mouse-eia-kit EIAs enzymes immunoassays immunometric kits assays measures measurements eggs whites immunization mice mouse chickens albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune response immunity OVA/alum immunized anti-OVA antibodies IgG1 IgE isotypes mediate tissue-specific tissues effectors chronic inflammation allergic asthma rhinitis cutaneous hypersensitivity antibody plasma serum immunoglobulin OVA-specific TH2 32.159345101738
10010275 Apigenin 520-36-5 >98% 2008-02-18 152.469861878452 apigenin Versulin; NSC 83244; Flavone; Chamomile flavonoids flavones CK2 inhibitors inhibits inhibition inflammatory response anti-inflammatory anti-oxidant NO PGE2 iNOS COX-2 I.kappa.B.alpha. NF-.kappa.-B renal cortex 152.469861878452
10008463 ApoAI Polyclonal Antibody - 2006-03-30 34.819992107340 apoai-polyclonal-antibody Apolipoprotein A-I; Apolipoprotein AI atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting 34.819992107340
90010 Arachidonic Acid 506-32-1 ≥98% 64.023038674033 arachidonic-acid fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential 64.023038674033
10007466 Arachidonic Acid-biotin - >98% 2005-11-30 29.261025168815 arachidonic-acid-biotin fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated 29.261025168815
10008617 Arachidonic Acid Leelamide - ≥95% 2006-09-27 13.333687845304 arachidonic-acid-leelamide AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic 13.333687845304
10007268 Arachidonic Acid Lipid Maps MS Standard 506-32-1 ≥98% 2009-07-06 16.677970534069 arachidonic-acid-lipid-maps-ms-standard fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards 16.677970534069
13622 AS-041164 Exclusive 1146702-72-8 ≥98% ✓ 2010-01-25 12.284825046040 as-041164 phosphoinositides 3-kinases PI3K cells growth migration metabolism inhibitors inhibits PI3Kα PI3Kβ PI3Kγ PI3Kδ chemotaxis inflammation neutrophils AS041164 AS-041164 RANTES 12.284825046040
10009052 AS-252424 900515-16-4 >95% 2007-01-30 30.902521704814 as-252424 phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 30.902521704814
10010175 AS-604850 Exclusive 648449-76-7 >98% ✓ 2007-07-23 15.371733425414 as-604850 phosphoinositides 3-kinases PI3-kinase PI3-K phosphatidylinositol inflammatory drugs inflammation arthritis rheumatoid peritonitis neutrophils recruitment PtdIns inhibitors inhibits inhibiton PI3K 15.371733425414
10007707 AS-605240 648450-29-7 >98% 2007-06-13 27.564988950276 as-605240 phosphoinositide 3-kinases PI3-kinase PI3-K PI3K phosphoinositide phosphatidylinositols inibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 27.564988950276
9000980 AS-605240 (potassium salt) Exclusive - ≥98% ✓ 2011-03-25 20.803078137332 as-605240-potassium-salt phosphoinositides 3-kinases PI3-kinases PI3-K PI3K phosphatidylinositols inhibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 as 605240 PIs salts solubility soluble 20.803078137332
13160 AT-56 Exclusive 162640-98-4 ≥95% ✓ 2010-06-22 14.424548802946 at-56 Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP 14.424548802946
10277 ATB-337 912758-00-0 ≥98% 2008-11-11 13.635399017802 atb-337 ACS 15; S-Diclofenac inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfides gasotransmitter vasodilator atb337 ACS-15 ACS15 ACS S SDiclofenac Diclofenac 13.635399017802
13045 ATB-343 Exclusive 1000700-26-4 ≥98% ✓ 2008-11-09 13.545159607121 atb-343 inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfide gasotransmitter vasodilator atb343 13.545159607121
600140 Autophagy/Cytotoxicity Dual Staining Kit - 2009-07-14 84.406214941364 autophagy-cytotoxicity-dual-staining-kit assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis 84.406214941364
10803 Autotaxin (human recombinant) - ≥95% 2011-04-04 24.261116022099 autotaxin-human-recombinant Ectonucleotide Pyrophosphatase/Phosphodiesterase-2; Lysophospholipase D; ENPP-2 lipids hydrolysis lysophophatidyl choline lysophophatidic acids secreated glycosylated 24.261116022099
700580 Autotaxin Inhibitor Screening Assay Kit - 2011-06-28 26.188143646409 autotaxin-inhibitor-screening-assay-kit ATX Inhibitor Screening Assay Kit kits assays measures measurements Ectonucleotides Pyrophosphatase-2 ENPP-2 Lysopholipases D hydrolysis lysophosphatidylcholines LPC lysophosphatidic acid LPA lipids mediators G protein-coupled receptors GPCRs neurogenesis angiogenesis smooth-muscles contraction platelets aggregations wounds healings ATX-LPA signaling tumors progression inflammation serums proteolytically peptides proteins N-glycosylation Asn53 Asn410 adipocytes cerebrospinal fluid multiple sclerosis livers fibrosis cancers genes chips analysis upregulated metastatic inhibits inhibition human 26.188143646409
10011336 Avenanthramide-C methyl ester Exclusive 955382-52-2 ≥95% ✓ 2009-06-18 68.208076343546 avenanthramide-c-methyl-ester Inhibitors NF-κB IL-6 IL-8 MCP-1 IκB inhibits inhibition Interleukins 68.208076343546
13823 AX 048 Exclusive 873079-69-7 ≥98% ✓ 2010-09-15 9.193425414365 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 9.193425414365
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 29.500721085946 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 29.500721085946
10960 Bisdemethoxycurcumin 24939-16-0 ≥98% 2011-08-09 5.449443726081 bisdemethoxycurcumin BDMC curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 5.449443726081
11071 BRD2 bromodomain 1 (human recombinant) New - ≥95% 2011-10-21 29.246960993221 brd2-bromodomain-1-human-recombinant RNF3; Bromodomain containing 4; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.246960993221
11070 BRD2 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 29.246960993221 brd2-bromodomain-2-human-recombinant RNF3; RING3; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.246960993221
11069 BRD2 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 54.677044294586 brd2-bromodomains-1-and-2-human-recombinant Bromodomain containing 2; RNF3; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 54.677044294586
11068 BRD4 bromodomain 1 (human recombinant) New - ≥60% 2011-10-21 39.863421170213 brd4-bromodomain-1-human-recombinant MCAP; HUNK1; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 39.863421170213
11066 BRD4 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 31.569969842779 brd4-bromodomain-2-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 31.569969842779
11052 BRD4 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 57.305076639599 brd4-bromodomains-1-and-2-human-recombinant HUNK1; MCAP; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 57.305076639599
10009599 Calcipotriol (hydrate) 112828-00-9 >98% 2008-02-08 43.350580110497 calcipotriol-hydrate Calcipotriene vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response 43.350580110497
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.557320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.557320441989
13907 Caspase-1 Monoclonal Antibody (Clone 14F468) - 2010-07-12 4.351128650355 caspase-1-monoclonal-antibody-clone-14f468 IL-1β Converting Enzyme antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins IL-1β ICE IL1β IL-1b IL1b apoptosis inflammatio 4.351128650355
70635 CAY10416 443919-96-8 >95% 2007-07-24 28.782914364640 cay10416 COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines 28.782914364640
10007955 CAY10498 863202-33-9 >98% 2006-08-02 31.301583793738 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 31.301583793738
10008657 CAY10502 Exclusive - >98% ✓ 2007-08-02 2.664198895028 cay10502 cPLA2.alpha. phospholipases inflammation inhibitors inhibits inhibition arthritis inhibitory cPLA2 AA arachidonic inflammatory inflammation 3-methyl hydrogen 1-[3-(4-decyloxy phenoxy)-2-oxopropyl] indole-3,5 dicarboxylate 2.664198895028
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.820911602210 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.820911602210
10010088 CAY10526 Exclusive 938069-71-7 >98% ✓ 2007-09-07 352.918618784530 cay10526 mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions 352.918618784530
10010032 CAY10570 Exclusive 875014-22-5 >98% ✓ 2008-06-03 16.145870165746 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 16.145870165746
10011248 CAY10575 916985-21-2 ≥95% 2008-09-03 28.167048145225 cay10575 IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB 28.167048145225
10011249 CAY10576 862812-98-4 ≥95% 2008-09-08 34.836049723757 cay10576 IKK-.epsilon. IKK.epsilon. IKK-epsilon IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition 34.836049723757
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 63.267826887661 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 63.267826887661
13164 CAY10589 Exclusive 1077626-52-8 ≥98% ✓ 2009-06-23 1.657500000000 cay10589 Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling 1.657500000000
13181 CAY10590 Exclusive 1101136-50-8 ≥98% ✓ 2009-04-15 15.854451460142 cay10590 sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells 15.854451460142
10012553 CAY10595 Exclusive 916047-16-0 ≥97% ✓ 2009-07-08 9.510211786372 cay10595 DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs 9.510211786372
10012539 CAY10597 916046-55-4 ≥98% 2009-03-11 4.356453038674 cay10597 DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid 4.356453038674
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 73.670928176795 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 73.670928176795
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.213069367710 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.213069367710
13381 CAY10606 1159576-98-3 ≥98% 2009-12-04 92.519167713700 cay10606 5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition 92.519167713700
13615 CAY10614 Exclusive 1202208-36-3 ≥98% ✓ 2010-03-22 10.774060773481 cay10614 1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation 10.774060773481
13695 CAY10638 Exclusive - ≥98% ✓ 2010-10-01 27.760269337016 cay10638 Thiazolidinedione derivative prostaglandins 15-PGDHs thiazolidinediones inhibitors inhibits inhibition TZDs derivatives PGDHs dehydrogenases 27.760269337016
10804 CAY10649 Exclusive - ≥98% ✓ 2011-04-04 18.383052005167 cay10649 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory 18.383052005167
10743 CAY10650 Exclusive 1233706-88-1 ≥98% ✓ 2011-06-14 23.657458563536 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 23.657458563536
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 30.332404939876 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 30.332404939876
10010117 CB-52 Exclusive 869376-90-9 ≥98% ✓ 2007-10-25 16.798142265193 cb-52 cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic 16.798142265193
10009852 CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8) - 2008-09-03 0.485303867403 cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence 0.485303867403
10232 CD5 Monoclonal FITC Antibody (Clone CRIS1) - 2009-08-10 4.574290976058 cd5-monoclonal-fitc-antibody-clone-cris1 Tp67; T1; Leu1 antibodies CDs flow cytometry immunocytochemistry ICC FC B-cells T-cell B T IHC IF immunofluorescence immunohistochemistry 4.574290976058
13519 Celastramycin A Exclusive 491600-94-3 ≥97% ✓ 2010-01-25 2.254419889502 celastramycin-a inhibits inhibitors bacterias mycobacterias inflammation IL-8 IL 8 IL8 HUVECs endothelial cells TNF-α TNFα TNF α inhibition interleukins tumors necrosis factors TNF alpha TNF.alpha. inflammatory bioactive endophytic celastraceae pyrroles 2.254419889502
13322 CGP 57380 522629-08-9 ≥95% 2009-08-28 33.420939226519 cgp-57380 MNK1 Inhibitor inhibitors inhibits inhibitions MAPKs MAP kinases interacting interacting-kinase 1 MNK1 p38 JNK1 ERK1/2 PKC Src-like phosphorylation elF4E TNF-a TNF-α TNFα TNFa arsenite anisomycin PMA fetal calf serum 293 cells RAW264.7 toll-like receptors TLR2 HKLM TLR4 LPS TLR6/2 FSL TLR7 imiquimod TLR9 CpG DNA CGP57380 CGP-57380 33.420939226519
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 65.399367710251 chemokine-like-receptor-1-polyclonal-antibody ChemR23; CMKLR1; DEZ; ChemerinR; GPCR ChemR23; Resolvin E1 Receptor immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 65.399367710251
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 53.389462581616 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 53.389462581616
10858 Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate 132465-11-3 ≥97% 2011-06-28 19.880372928176 cinnamyl-3-4-dihydroxy-cyanocinnamate CDC inhibitors 5-LO 5LO 12LO 15LO 5 LO 12 LO 15 LO 12-LO 15-LO LTB4 lipoxygenases immune responses inflammation inhibits inhibition A23187 platelets shock assays 19.880372928176
10004235 cis-Resveratrol 61434-67-1 >98% (may contain 1-5% trans) 2008-02-05 27.162389502762 cis-resveratrol (Z)-Resveratrol antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 27.162389502762
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 1.970441988950 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 1.970441988950
10009624 COX-2 (human) Western Ready Control - Whole cell lysate 2007-04-30 52.972715074979 cox-2-human-western-ready-control Cyclooxygenase-2; Prostaglandin H Synthase 2 western blots WB PGHS-2 Prostaglandin H Synthase 2 cyclooxygenase 2 52.972715074979
10010096 COX-2 (mouse) Polyclonal FITC Antibody Exclusive - ✓ 2008-04-23 31.123784530387 cox-2-mouse-polyclonal-fitc-antibody Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2 antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting IF immunofluorescence 31.123784530387
700200 COX Fluorescent Activity Assay Kit - 2008-07-24 77.425905102372 cox-fluorescent-activity-assay-kit Cyclooxygenase Fluorescent Activity Assay Kit cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 77.425905102372
13183 CP 80633 135637-46-6 ≥98% 2010-05-20 11.495745856353 cp-80633 phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 Pyrimidinones Pyrimidones 11.495745856353
10011236 C-Reactive Protein (human) EIA Kit - 2009-04-22 292.398823204420 c-reactive-protein-human-eia-kit CRP (human) EIA Kit atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs 292.398823204420
580200 CTRP3 (human) EIA Kit New - 2012-01-20 7.292605184870 ctrp3-human-eia-kit Complement C1q TNF-related Protein 3 kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants 7.292605184870
10329 Cystathionine γ-Lyase (human recombinant) - ≥85% 2010-02-19 5.410607734807 cystathionine-lyase-human-recombinant CTH; Cystathionase; CGL cystathionases CTH CGL cystathionines gamma-lyase γ homocysteine transsulfuration cysteines hydrogen sulfides cystathionine gamma-lyase proteins enzymes .gamma.-lyase g-lyase 5.410607734807
10009291 Cysteinyl Leukotriene Express EIA Kit - 2008-08-11 219.322250125565 cysteinyl-leukotriene-express-eia-kit CysLT Express ELISA Kit solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs 219.322250125565
10961 Demethoxycurcumin New 22608-11-3 ≥98% 2011-09-23 5.123579797029 demethoxycurcumin DMC curcumin cancers transcription genes expressions p300 Wnt/β-catenin iNOS inflammation proliferation cells p300 coactivator inhibits lipopolysaccharides inhibitor inhibition 5.123579797029
11015 Dexamethasone New 50-02-2 ≥98% 2011-10-25 65.599524557757 dexamethasone MK 125; NSC 34521 steroids hormones glucocorticoid agonist receptors inflammation genes expression anti-inflammatory antiinflammatory anti inflammatory 8054-59-9 137098-19-2 906362-70-7 906422-84-2 1050677-47-8 adexone aeroseb-Dex aphtasolon aphthasolone azium calonat corsone cortisumman decacort decaderm decadron A decalix decasone dekacort dekort delipos deltafluorene dergramin deronil desadrene desameton deseronil dexa-cortidelt dexa-mamallet dexa-scheroson dexa-sine dexacort dexacortal dexacortin dexadeltone dexafarma dexalona dexaltin dexameth dexamethasone alcohol dexamonozon dexapolcort dexapos dexaprol dexason dexasone dexinoral dexmethsone dexone dexonium dextelan dinomon diodex etacortilen fluormone fluorocort gammacorten gentalipos HL-dex hexadecadrol hexadrol isopto-dex lokalison F loverine luxazone MK-125 MK125 maxidex millicorten NSC-34521 NSC34521 oradexon pet-derm III posurdex prednisolon F prednisolone superprednol surodex visumetazone 65.599524557757
10010948 DL-Propargyl Glycine (hydrochloride) - ≥98% 2008-08-19 43.013158379374 dl-propargyl-glycine-hydrochloride PAG (hydrochloride) H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine 43.013158379374
9090310 Docosahexaenoic Acid ethyl ester 1020718-25-5 ≥98% 2009-01-15 60.934944751381 docosahexaenoic-acid-ethyl-ester DHA ethyl ester; Cervonic Acid ethyl ester fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism 60.934944751381
10460 Doramapimod 285983-48-4 ≥98% 2011-06-02 18.385745856353 doramapimod BIRB-796 p38 MAPKs inflammation TNFα TNF-α TNF α TNFalpha TNF-alpha TNF alpha JNKs inhibitors proteins kinases tumors necrosis factors LPS THP.1 cells THP1 BIRB796 BIRB 796 mitogen activated mitogen-activated proinflammatory cytokins interleukin-1 IL IL-1 interleukin 1 18.385745856353
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 21.396132596684 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 21.396132596684
500480 dsDNA Autoantibody (human) EIA Kit New - 2011-10-07 7.086614173228 dsdna-autoantibody-human-eia-kit Anti-double stranded DNA EIA EIAs ELISAs enzymes immunoassays kits measures measurement autoimmunity neutrophils extracellular traps NETs histones peptides deoxyribonucleic acids DNAse I-mediated DNA-degrading plasma systemic lupus erythematosus SLE autoantibodies double stranded dsDNA IgG anti-dsDNA autoimmune diseases immunometric isotypes human serum affinity-purified antibody calf thymus poly-L-lysine protamine sulfate 7.086614173228
10007963 E-64 66701-25-5 ≥98% 2009-11-12 54.998232044198 e-64 inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 54.998232044198
10007964 E-64c 76684-89-4 ≥98% 2006-08-02 52.925580110497 e-64c EP 475; Loxistatin Acid; NSC 694279 E-64 cysteine protease cell cycle inhibitor E-64d 52.925580110497
10111 EA4 - ≥95% 2005-10-12 8.368784530386 ea4 phospholipase A2 cPLA2 RBCs red blood cells CYP1A1 CYP1B1 cytochromes P450 cytosolic cow bovine human group IV quinones derivatives inhibits inhibition rPLA2 ionophore-induced ionophores arachidonic acids release calcium Ca2+-dependent Ca+2 mammalian mRNA proteins mouse murine hepatoma Hepa-1c1c7 MCF-7 Hep-G2 HL-60 8.368784530386
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated product 2005-08-30 232.708402836386 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 232.708402836386
9000295 Eicosapentaenoic Acid methyl ester New 2734-47-6 ≥98% 2011-10-07 41.874288583402 eicosapentaenoic-acid-methyl-ester EPA vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs 41.874288583402
10964 Eicosapentaenoyl Ethanolamide 109001-03-8 ≥98% 2011-06-22 40.873259668508 eicosapentaenoyl-ethanolamide EPEA cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory 40.873259668508
10569 Ellagic Acid 476-66-4 ≥95% 2010-10-13 6.173474524248 ellagic-acid Lagistase; TBBD; Gallogen polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid 6.173474524248
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 24.681933701657 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 24.681933701657
600340 EP2 Receptor (rat) STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-09-20 23.550653775322 ep2-receptor-rat-step-reporter-assay-kit-luminescence Prostaglandin E2 Receptor 2; PGE2 Receptor 2 prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP3 EP4 signal transduction tissues regulation cells mediates cAMP cyclic messenger pathways mucosal protection gastrointestinal secretions motility immunity inflammation mice mouse murine tumors cancers cancer-associated immunodeficiency dendritic-cell differentiation in vitro neuroprotective NMDA toxicity oxygen glucose deprivation agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening 23.550653775322
600410 EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) - 2011-06-28 6.746537753222 ep4-receptor-rat-step-plate-assay-kit-camp-method cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular 6.746537753222
10008610 Epoxy Fluor 7 Exclusive 863223-43-2 ≥98% ✓ 2006-08-30 10.751329419889 epoxy-fluor-7 epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology 10.751329419889
10009798 EX-527 49843-98-3 ≥98% 2009-10-23 26.102891344382 ex-527 sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 26.102891344382
10009549 FABP4 (human recombinant) - >90% 2007-06-15 30.360148746281 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 30.360148746281
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; FABP4; A-FABP fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.106180939226 fabp4-human-recombinant-western-ready-control Fatty Acid Binding Protein 4; Adipocyte-FABP; ALBP; FABP4; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.106180939226
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 10.065867403314 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 10.065867403314
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 4.295814917127 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 4.295814917127
10610 F-Amidine (trifluoroacetate salt) Exclusive New - ≥95% ✓ 2011-09-23 18.138630420943 f-amidine-trifluoroacetate-salt proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine 18.138630420943
13563 FIPI Exclusive 939055-18-2 ≥98% ✓ 2010-03-24 28.454795580110 fipi 5-Fluoro-2-Indolyl des-Chlorohalopemide Phospholipases D PLD phosphatidic acids PA Ras activation cells spreading stress fiber formation chemotaxis membrane vesicles trafficking halopemide inhibitors inhibits inhibition PLD1 PLD2 F-actin cytoskeletons inflammation arthritis Pharmascience Brand of Domperidone Maleate Stadapharm Brand of Domperidone Maleate Ratiopharm Brand of Domperidone Maleate Taxandria Brand of Domperidone Maleate Novopharm Brand of Domperidone Maleate Nu-Pharm Brand of Domperidone Maleate Nu Pharm Brand of Domperidone Maleate Apotex Brand of Domperidone Maleate Hexal Brand of Domperidone Maleate Aliud Brand of Domperidone Maleate Teva Brand of Domperidone Maleate Pierre Fabre Brand of Domperidone Gry Brand of Domperidone Maleate Rottapharm Brand of Domperidone Monohydrochloride, Domperidone Domperidone Monohydrochloride Janssen Brand of Domperidone Domperidone Maleate (1:1) Maleate, Domperidone Domperidone Maleate Gamir Domperidona Stada Domperidon ratio-Domperidone ratio Domperidone Hexal Domperidon Domperidona Gamir Novo-Domperidone Novo Domperidone Domperidon Stada Domperidon Hexal PMS-Domperidone PMS Domperidone Domperidon-TEVA Domperidon TEVA Apo-Domperidone Apo Domperidone Nu-Domperidone Nu Domperidone Domperidon AL Domperidone Gastrocure Domperidon R-33,812 Nauzelin Motilium R-33812 R33,812 Péridys Domidon R33812 28.454795580110
10039 FR122047 (hydrate) - ≥98% 9.722624309392 fr122047-hydrate 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis 9.722624309392
13254 FTY720 phenoxy-biotin Exclusive - ≥95% ✓ 2009-10-28 67.725870165746 fty720-phenoxy-biotin sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide 67.725870165746
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 25.639433701658 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 25.639433701658
10566 Garcinol New 78824-30-3 ≥95% 2011-10-25 11.209988941663 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 11.209988941663
10010622 Genipin 6902-77-8 ≥98% 2008-05-09 99.322569060774 genipin (+)-Genipin obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity 99.322569060774
10011356 Glycerophospho-N-Palmitoyl Ethanolamine Exclusive 100575-09-5 ≥98% ✓ 2009-03-12 11.982209944751 glycerophospho-n-palmitoyl-ethanolamine GP-NPEA; GP-NAE cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic 11.982209944751
13127 GW 4869 6823-69-4 ≥90% 2009-06-10 48.048139963167 gw-4869 inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 48.048139963167
10009162 GW 627368X Exclusive 439288-66-1 ≥96% ✓ 2007-05-14 22.181139502762 gw-627368x EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X 22.181139502762
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 35.737209944751 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 35.737209944751
10010410 GW 848687X 612831-24-0 ≥98% 2009-11-25 15.437038674033 gw-848687x Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X 15.437038674033
13345 GYY 4137 Exclusive 106740-09-4 ≥95% ✓ 2009-07-31 111.395851749539 gyy-4137 hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 111.395851749539
10009465 HDAC6 (human recombinant) - >80% 2007-06-14 34.513968909042 hdac6-human-recombinant GenBank Accession No. BC069243; Histone Deacetylase 6 HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 34.513968909042
10009466 HDAC9 (human recombinant) - >95% 2007-06-14 19.766168896397 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 19.766168896397
10006809 Heptanoyl thio-PC - ≥98% 2005-10-05 9.486878453039 heptanoyl-thio-pc sPLA2s substrates colorimetrics phospholipases thioesters analogs glycerophospholipids Ellman's reagent measurements activity diheptanoyl thio-PC ether-linked saturated C16 moiety sn-1 position modifications resistant PLA1 pig porcine pancreatic bee venom 9.486878453039
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 131.388888888888
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 77.222222222222 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 77.222222222222
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 131.388888888888
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 134.722222222222 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 134.722222222222
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 143.055555555555 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 143.055555555555
10888 HZ52 New 1077626-51-7 2011-09-30 19.619849784228 hz52 inhibitors inhibits inhibition 5-LO 5 LO 5LO leukotrienes LTBs LTB4 LTs leukocytes neutrophils inflammation shock HZ-52 HZ 52 19.619849784228
13930 IKKγ Monoclonal Antibody (Clone 46B844) - 2010-10-20 18.219091467157 ikk-monoclonal-antibody-clone-46b844 NF-κB Essential Modulator; NEMO; IKK3 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots immunoblotting WB blotting flow cytometry FC intracellular 18.219091467157
13931 IKKγ Monoclonal Antibody (Clone 72C627) - 2010-11-08 19.422283609576 ikk-monoclonal-antibody-clone-72c627 NF-κB Essential Modulator; NEMO; IKK3 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots WB blotting 19.422283609576
13929 IKKε Monoclonal Antibody (Clone 72B587) - 2010-10-20 18.219091467157 ikk-monoclonal-antibody-clone-72b587 TBK1; IKKi antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 18.219091467157
13928 IKKε Polyclonal Antibody - 2010-10-20 18.219091467157 ikk-polyclonal-antibody IKKi antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 18.219091467157
10809 Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) - 2011-06-03 0E-12 interleukin-33-human-monoclonal-antibody-clone-il33305b NF-HEV; IL-33; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10811 Interleukin-33 Monoclonal Antibody (Clone IL33026B) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il33026b IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10810 Interleukin-33 Monoclonal Antibody (Clone IL333068A) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il333068a IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 24.633523634131 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 24.633523634131
13843 IRAK-1 Polyclonal Antibody - 2010-11-11 0E-12 irak-1-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase 1 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 receptors signaling cascase activation members novel cytokines IL-18 IL18 18 IGIF antibodies western blots blotting immunoblotting WB IP immunoprecipatation IRAK-1 0E-12
13844 IRAK-2 Polyclonal Antibody - 2010-11-18 0E-12 irak-2-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase-Like 2 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 antibodies western blots blotting immunoblotting WB IL-1RI signaling cascade activation IRAK-2 IRAKs 2 pelle proteins kinases drosophila cytokine oligonucleotides inhibits inhibition IL-18 IL18 anti-sense antisense AP-1 AP1 APs 1 IRAK2 0E-12
13845 IRAK-4 Polyclonal Antibody - 2010-11-18 0.261444356748 irak-4-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase-Like 4 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB antibodies toll-like toll like receptors interleukin-1 IL-1 IL1 IL TLRs mammal transmembranes trans membranes IRAKs TRAF6 TRAF-6 TRAFs 6 MyD88 MAPK pathways LPS activation murine viral bacterial antibodies western blots WB immunoblotting blotting immunoprecipitation IP IRAK4 0.261444356748
10739 Isoliquiritigenin 961-29-5 ≥98% 2011-04-01 40.539204419889 isoliquiritigenin ISL; GU 17 antioxidants flavonoids chemoprevention quinones reductase-1 reductase1 hepatoprotection hepatoma cells flavanoids 40.539204419889
13925 IκBα (cleavage specific) Monoclonal Antibody (Clone 5D1623) - 2010-09-29 10.997200736648 i-b-cleavage-specific-monoclonal-antibody-clone-5d1623 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target cleaved caspases caspase-3 3 apoptosis amino-terminal amino terminals truncated DN-IκBα DNIκBα DN ΔN-IκBα ΔN .DELTA.N DELTAN .DELTA.N-IκBα DELTAN-IκBα DELTA-N .DELTA.-N degradation inducers dominant inhibitory molecule suppresses activity inflammation 10.997200736648
13922 IκBα Monoclonal Antibody - biotin (Clone 6A920) - 2010-09-27 14.873129080863 i-b-monoclonal-antibody-biotin-clone-6a920 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target ELISA biotinlated biotins 14.873129080863
13918 IκBα Monoclonal Antibody (Clone 6A920) - 2010-09-23 14.873129080863 i-b-monoclonal-antibody-clone-6a920 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α flow cytometry FC intracellular immunohistochemistry IHC paraffin-embedded sections paraffin embedded immunoprecipitation IP western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 14.873129080863
13924 IκBα (Phospho-Ser32/36) Monoclonal Antibody - biotin (Clone 39A1413) - 2010-09-29 0.140883977900 i-b-phospho-ser32-36-monoclonal-antibody-biotin-clone-39a1413 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser EIA ELISA biotins biotinylated inflammation genes regulation signal transduction 0.140883977900
13923 IκBα (Phospho-Ser32/36) Monoclonal Antibody (Clone 39A1413) - 2010-09-29 15.769663485685 i-b-phospho-ser32-36-monoclonal-antibody-clone-39a1413 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target immunoprecipitation IP serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser genes regulation inflammation signal transduction 15.769663485685
13921 IκBα Polyclonal Antibody - 2010-09-23 0.140883977900 i-b-polyclonal-antibody antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 0.140883977900
13919 IκBα Polyclonal Antibody (aa 34-48) - 2010-09-23 14.873129080863 i-b-polyclonal-antibody-aa-34-48 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB antibodies IκBα IkBa IκBa IkBα IκB-α IκB α slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 14.873129080863
9000059 (±)-Jasmonic Acid methyl ester 39924-52-2 ≥95% (mixture of isomers) 2009-04-01 4.540696132596 -jasmonic-acid-methyl-ester (±)-Methyl Jasmonate cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory 4.540696132596
10011925 JNJ-7777120 459168-41-3 ≥98% 2011-02-24 2.119060773480 jnj-7777120 histamines H4 receptors antagonists inflammation Piperazines 2.119060773480
10009018 JWH 015 155471-08-2 ≥98% 2006-10-05 71.726170738024 jwh-015 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 71.726170738024
10660 JWH 015-d7 Exclusive - ≥99% deuterated product ✓ 2011-02-21 49.700773480663 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 49.700773480663
9001148 Ketorolac New 74103-06-3 ≥98% 2012-01-12 102.551822259998 ketorolac Sprix®; Acular PF®; RS 37619; Acular LS® analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 102.551822259998
10011565 L-161,982 147776-06-5 ≥98% 2009-02-26 59.377173112339 l-161-982 PGEs PGE2 EPs EP4 receptors antagonist bone formation inflammation cells proliferation colon cancers L161982 L-161982 59.377173112339
10007712 L-902,688 Exclusive 634193-54-7 ≥98% ✓ 2010-05-07 44.592225730070 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 44.592225730070
10010329 Lavendustin C 125697-93-0 ≥98% 2008-07-08 13.559254143646 lavendustin-c HDBA; NSC 666251 EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C 13.559254143646
10006148 Leelamine 1446-61-3 >98% 2006-05-10 0.520865561694 leelamine Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.520865561694
10008614 Leelamine (hydrochloride) - ≥98% 2006-05-10 0.419208103131 leelamine-hydrochloride Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.419208103131
10007817 Leukotriene A4 Hydrolase (human recombinant) - >90% 2005-12-14 257.451246163290 leukotriene-a4-hydrolase-human-recombinant LTA4H leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis 257.451246163290
20110 Leukotriene B4 71160-24-2 ≥97% 184.036077348066 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 184.036077348066
20114 Leukotriene B4-3-aminopropylamide 89596-43-0 ≥95% 2009-03-05 341.608637200736 leukotriene-b4-3-aminopropylamide LTB4-3-aminopropylamide LTB LTB4 BLTs BLT1 BLT2 inflammation immunology 341.608637200736
20112 Leukotriene B4 Ethanolamide - >97% 31.231933701657 leukotriene-b4-ethanolamide LTB4-EA BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines 31.231933701657
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 32.633635359115 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 32.633635359115
10006198 Leukotriene C4-d5 - ≥99% deuterated product 2007-04-11 98.847513812155 leukotriene-c4-d5 LTC4-d5 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 98.847513812155
10007692 Licofelone 156897-06-2 ≥98% 2006-04-03 35.333449969306 licofelone ML 3000 inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 35.333449969306
10011453 Lipoxin A5 Exclusive 110657-98-2 ≥95% ✓ 2008-11-17 55.738222836095 lipoxin-a5 LXA5 EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs 55.738222836095
10010785 (±)-Lisofylline 6493-06-7 ≥98% 2009-09-18 17.697113259669 -lisofylline CT-1501R; BL 194; LSF pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 17.697113259669
700570 L-Theanine Fluorometric Assay Kit Exclusive - ✓ 2011-05-31 240.716457949662 l-theanine-fluorometric-assay-kit 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins 240.716457949662
500260 Luminex® Leukotriene B4 Kit - 2008-11-12 41.790320441989 luminex-leukotriene-b4-kit Luminex® LTB4 Kit leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays 41.790320441989
10007502 Luminex® Thromboxane B2 Kit - 2009-07-13 32.902615101289 luminex-thromboxane-b2-kit Luminex® TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 32.902615101289
10010024 LY223982 Exclusive 117423-74-2 ≥98% ✓ 2008-07-24 6.007845303868 ly223982 SKF 107324; CGS 23131 LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 6.007845303868
10009768 LY293111 Exclusive 161172-51-6 ≥98% ✓ 2009-02-09 90.203204419890 ly293111 Etalocib; VML 295 LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers 90.203204419890
10172 Lyso-PC 17364-16-8 >98% 2004-03-02 14.726318432947 lyso-pc lysopc signals transduction pathways G2A receptors lipids phosphatidylcholines phospholipases PLAs hydrolysis lysophosphatidic acid lysophosphatidyl choline LPA 14.726318432947
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 19.969640883978 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 19.969640883978
13320 MCI-186 89-25-8 ≥98% 2010-07-15 26.090883977899 mci-186 Edaravone; NSC 2629 free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries Ketoquinolines Oxoquinolines Quinolinones Quinolones strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone 26.090883977899
10639 MDA 77 Exclusive 1103774-21-5 ≥98% ✓ 2011-05-16 4.063591160221 mda-77 CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay 4.063591160221
13847 MEK2 Polyclonal Antibody - 2010-11-18 0E-12 mek2-polyclonal-antibody MAPKK2; MAP Kinase Kinase 2; Dual Specificity MAP Kinase Kinase 2; MAP Kinase/ERK Kinase 2 MEKs MEK-2 MEK2 MAPKs kinases MAP ERKs phosphorylation antibodies serine cytokines growth factors tranduction mitogenic signals western blots blotting immunoblotting 0E-12
13848 MEKK2 Polyclonal Antibody - 2010-12-21 0E-12 mekk2-polyclonal-antibody Dual Specificity MAP Kinase Kinase Kinase 2; MAP Kinase/ERK Kinase Kinase 2; MAP Kinase Kinase Kinase 2; MAP3K2; MAPKKK2 MEKs MEK-2 MEK 2 MAPKs kinases MAPs mitogen-activated mitogen activated proteins signaling pathway phosphorylate IkB I.kappa.B IkappaB IκB NF-κB NF-kappaB NF-.kappa.B NFκB NF.kappa.B NFkB T-cells T cells cytokine genes expressions mast cells epidermal growth factor EGRs fibroblast growth factor-2 factor 2 FGF-2 FGF2 FGFs 2 signals rheumatoid arthritis LPS-TLR4 LPS TLR4 TLR-4 TLR 4 ligands phosphorylation western blots blotting immunoblotting WB immunohistochemistry IHC MAP kinase kinase kinase 0E-12
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 208.421613259668 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 208.421613259668
10010252 Methyl-L-NIO (hydrochloride) 150403-96-6 >98% 2008-02-12 7.353508287293 methyl-l-nio-hydrochloride NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation 7.353508287293
500400 Mouse Anti-Type II Collagen IgG Assay Kit (Qualitative, bovine) New - 2011-10-14 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-bovine EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500420 Mouse Anti-Type II Collagen IgG Assay Kit (Qualitative, chick) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-chick EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500410 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, bovine) New - 2011-10-14 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-bovine EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500430 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, chick) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-chick EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500470 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, mouse) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-mouse EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
10004910 Mouse Macrophage Microsomal Immunoblot Control - 2004-11-09 30.565807243707 mouse-macrophage-microsomal-immunoblot-control Mouse macrophage microsomes protein western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE 30.565807243707
13746 MyD88 Polyclonal Antibody - 2010-02-05 29.239033149171 myd88-polyclonal-antibody proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling 29.239033149171
10006438 Myeloperoxidase Chlorination Assay Kit - 2009-04-14 118.434392265193 myeloperoxidase-chlorination-assay-kit MPO Chlorination Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl 118.434392265193
700170 Myeloperoxidase Inhibitor Screening Assay Kit - 2009-04-14 94.095513812154 myeloperoxidase-inhibitor-screening-assay-kit MPO Inhibitor Screening Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays 94.095513812154
700160 Myeloperoxidase Peroxidation Assay Kit - 2009-04-14 108.479337016574 myeloperoxidase-peroxidation-assay-kit MPO Peroxidation Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 108.479337016574
10007704 N-(3-hydroxyphenyl)-Arachidonoyl amide Exclusive 183718-75-4 >98% ✓ 2007-02-02 13.166132596685 n-3-hydroxyphenyl-arachidonoyl-amide 3-HPAA neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic 13.166132596685
10008284 N-acetyl-2-carboxy Benzenesulfonamide Exclusive 849067-18-1 >98% ✓ 2006-05-10 12.068987108655 n-acetyl-2-carboxy-benzenesulfonamide analogs aspirin inhibits inhibitors inhibition cyclooxygenaes COX-1 COX-2 COX1 COX2 12.068987108655
11189 N-acetyl-Pro-Gly-Pro Peptide New - ≥95% by HPLC 2012-02-02 127.385079189686 n-acetyl-pro-gly-pro-peptide N-acetyl-PGP chemokines receptors ligands COPD cystic fibrosis neutrophils infiltration PMN chemoattractants CXC ECM PGP metabolites BAL bronchoalveolar inflammation inflammatory diseases 127.385079189686
579040 Nampt/Visfatin (mouse/rat) EIA Kit - 2011-08-08 31.252213966681 nampt-visfatin-mouse-rat-eia-kit Nicotinamide Phophoribosyltransferase/Visfatin Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse 31.252213966681
16841 NBD-FTY720 phenoxy (hydrochloride) - ≥96% 2009-08-04 66.481657458564 nbd-fty720-phenoxy-hydrochloride sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 fluorescent fluorescence FTY720-phosphates sphingosines immunosuppression immune modulators transporters cPLA2 cytosolic phospholipases A2 phosphorylation 66.481657458564
13570 N-Benzylacetamidine (hydrobromide) 186545-76-6 ≥98% 2010-02-11 32.162348066299 n-benzylacetamidine-hydrobromide NO nitric oxide synthases NOS iNOS inflammation immune responses eNOS inhibitors inhibits inhibition inflammatory alpha-D-N-Acetyl-Galactosaminyloligosaccharidase alpha D N Acetyl Galactosaminyloligosaccharidase alpha-D-N-Acetylgalactosaminyloligosaccharidase alpha D N Acetylgalactosaminyloligosaccharidase endo-N-Acetyl-alpha-D-Galactosamidase endo N Acetyl alpha D Galactosamidase endo-alpha-N-Acetylgalactosaminidase endo alpha N Acetylgalactosaminidase N-Acetyl-alpha-D-Galactosaminidase N Acetyl alpha D Galactosaminidase alpha-N-Acetyl-D-galactosaminidase alpha N Acetyl D galactosaminidase alpha-N-Acetylgalactosaminidase alpha N Acetylgalactosaminidase alpha-Galactosidase B alpha Galactosidase B 32.162348066299
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 45.398432320442 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 45.398432320442
13755 NF-κB (p50) Monoclonal Antibody (Clone 2J10D7) - 2010-02-05 11.545441988950 nf-b-p50-monoclonal-antibody-clone-2j10d7 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry 11.545441988950
13754 NF-κB (p50) Polyclonal Antibody - 2010-04-27 11.545441988950 nf-b-p50-polyclonal-antibody NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies 11.545441988950
10010184 NF-κB (p50) Western Ready Control - Whole cell lysate 2007-07-19 47.071057616416 nf-b-p50-western-ready-control Nuclear Factor-κB (p50); NF-κB1 western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals 47.071057616416
13756 NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021) - 2010-02-11 22.794680347277 nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones 22.794680347277
13752 NF-κB (p65) Monoclonal Antibody (Clone 112A1021) - 2010-02-11 25.778105761641 nf-b-p65-monoclonal-antibody-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC 25.778105761641
13751 NF-κB (p65) NLS Polyclonal Antibody - 2010-02-11 24.958658247829 nf-b-p65-nls-polyclonal-antibody Nuclear Factor-κB (p65) Nuclear Localization Signal NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies 24.958658247829
13757 NF-κB (p65) Polyclonal Antibody (aa 2-17) - 2010-02-11 18.005414364640 nf-b-p65-polyclonal-antibody-aa-2-17 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 18.005414364640
13753 NF-κB (p65) Polyclonal Antibody (aa 538-546) - 2010-02-11 22.794680347277 nf-b-p65-polyclonal-antibody-aa-538-546 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 22.794680347277
10006966 Nitrotyrosine Monoclonal Antibody - Biotinylated - 2005-04-15 16.365000000000 nitrotyrosine-monoclonal-antibody-biotinylated antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays 16.365000000000
13390 N-methyl Leukotriene C4 131391-65-6 >97% 2008-10-15 55.846749539595 n-methyl-leukotriene-c4 N-methyl LTC4 allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics 55.846749539595
10004971 N,N'-Dicyclohexylurea 2387-23-7 ≥98% 2010-03-17 16.488798342541 n-n-dicyclohexylurea DCU; NSC 17013 hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide Doms-Adrian Brand of Alanine Doms Adrian Brand of Alanine Alanine Doms-Adrian Brand Alanine, L-Isomer Alanine, L Isomer L-Isomer Alanine L-Alanine L Alanine Alanine Abufène 16.488798342541
10004942 Nod2 Monoclonal Antibody (Clone 2D9) - 2004-09-08 19.118497763746 nod2-monoclonal-antibody-clone-2d9 antisera antibody antibodies nod1 apoptosis nf kb nf-kb nf-.kappa.b nf-kappab crohn's diseases inflammations inflammatory bowel nod-2 nod-1 antiserum apoptosis caspases CARDs western blots blotting WB immunohistochemical immunohistochemistry IHC nfkb immunoblotting 19.118497763746
11040 Nodinitib-1 New 799264-47-4 ≥95% 2012-01-20 81.298793738490 nodinitib-1 ML130; CID-1088438 NOD1 NLR innate immunity NF-κB signaling inflammation MAPK inflammatory diseases inhibitors inhibition inhibits NACHT leucine proteins bacterial bacteria ligands stress kinases interferons polymorphisms genes asthma bowel multiple sclerosis MS cells CD83 CD86 HLA-DR IL-1β IL-6 TNFα 81.298793738490
10005705 NO-Indomethacin Exclusive 301838-28-8 >98% ✓ 2004-10-20 6.229944751381 no-indomethacin NCX 2121 inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic 6.229944751381
10010411 NS-304 475086-01-2 >98% 2008-04-09 41.397650158956 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 41.397650158956
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 1.869005524861 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 1.869005524861
10784 PAD1 (human recombinant) - ≥95% 2011-05-12 19.455773480663 pad1-human-recombinant Protein-Arginine Deiminase 1 PAD1 PADI-1 arginine deiminase post-translational modifications citrullination skin keratinocytes calcium-dependent 19.455773480663
500930 PAD4 Autoantibody EIA Kit New - 2011-08-18 6.925602947402 pad4-autoantibody-eia-kit Protein Arginine Deiminase 4; Peptidylartginine Deaminase 4 peptidylarginine deiminase proteins arginines deiminases 4 guanidine guanidino-modifying enzymes amidinotransferases superfamily homodimers transcriptional coregulators catalyzes residues citrulline calcium-dependent rheumatoid arthritis RA arthritogenic autoantibodies citrullinated peptides cyclics CCP anti-CCP immunoassays immunometrics assays kits measures measurement isotypes IgM IgG IgA human plasmas serums 6.925602947402
10500 PAD4 (human recombinant) - ≥95% 2010-05-27 33.019177029619 pad4-human-recombinant Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase 33.019177029619
10279 PAF Acetylhydrolase (human recombinant) - ≥95% 2008-06-19 28.530149960536 paf-acetylhydrolase-human-recombinant Lp-PLA2; PAF-AH; Platelet-Activating Factor Acetylhydrolase; Lipoprotein PLA2 proteins PAFs lipids mediator inflammation PAFAH enzymes PAF AH phospholipases PLA2s inflammatory N-terminal His-tags His-tagged 28.530149960536
10010081 PAF Acetylhydrolase (human) Western Ready Control - 2007-05-30 5.758508287292 paf-acetylhydrolase-human-western-ready-control PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 western blotting WB atherosclerosis factors asthma inflammation PAFs 5.758508287292
360900 PAF C-16-d4 - ≥99% deuterated product 22.865635359116 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 22.865635359116
10010521 Palmitoyl thio-PC 113881-60-0 ≥98% 2008-05-23 14.835676795580 palmitoyl-thio-pc thioesters PLA2s substrates sPLA2 cPLA2 sn-2 analogs absorbance micelle systems 14.835676795580
10992 PAX5 Polyclonal Antibody New - 2011-12-06 26.666666666667 pax5-polyclonal-antibody BSAP transcription factors B cells development IL-7 phosphorylated STAT5 Western blots blotting WB IL7 IL 7 STAT-5 STAT 5 PAX-5 PAX 5 26.666666666667
10010907 PF-622 898235-65-9 >98% 2008-03-26 6.383455163621 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 6.383455163621
10010908 PF-750 959151-50-9 >98% 2008-03-25 11.288732734806 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 11.288732734806
13454 PGDM New 133161-96-3 ≥90% (mixture) 2012-02-02 150.276255180749 pgdm Prostaglandin D Metabolite PGD-M urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures 150.276255180749
11344 PGDM-d4 New - ≥99% deuterated forms (d1-d4) 2012-02-02 150.276255180749 pgdm-d4 Prostaglandin D Metabolite-d4 PGD-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous allergic asthmatic sleep body temperatures 150.276255180749
500290 Phagocytosis Assay Kit (IgG FITC) - 2009-04-09 159.949601011710 phagocytosis-assay-kit-igg-fitc kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba 159.949601011710
600540 Phagocytosis Assay Kit (IgG PE) New - 2012-01-10 160.725041052793 phagocytosis-assay-kit-igg-pe kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence 160.725041052793
10009210 PIK-75 372196-67-3 ≥98% 2010-03-10 16.997085716132 pik-75 p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g Mixtures, Sulfonamide Sulfonamide Mixtures Sulfonamides 16.997085716132
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 17.139206349206 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 17.139206349206
11004 Podoplanin Monoclonal Antibody (Clone NZ-1.2) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-nz-1-2 Aggrus; T1A; gp38 mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies 0E-12
11005 Podoplanin Monoclonal Antibody (Clone pmab-1) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-pmab-1 Aggrus; gp38; T1A gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation 0E-12
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.257910597690 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.257910597690
13327 PPM-18 65240-86-0 ≥95% 2010-09-15 8.838674033149 ppm-18 NSC 73233 inhibitors inhibits inhibition NF-κB NFκB NF κB NF-kB NFkB kB iNOS inflammation sepsis inducible nitric oxides synthases inflammatory NO Naphthalenediones Naphthoquinones Naphthazarins 8.838674033149
10006973 Pravadoline 92623-83-1 ≥98% 2011-02-08 49.107296654389 pravadoline WIN 48,098 Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 49.107296654389
500940 Progranulin (human) EIA Kit - 2011-04-26 27.290078623034 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 27.290078623034
500950 Progranulin (mouse) EIA Kit - 2011-04-26 36.071109064866 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 36.071109064866
11188 Prolyl-glycyl-proline Peptide New - ≥95% by HPLC 2012-02-02 127.385079189686 prolyl-glycyl-proline-peptide PGP LTA4 hydrolases substrates COPD cystic fibrosis neutrophils infiltration CF MMP-8 MMP-9 CXCR1 CXCR2 chemoattractants 127.385079189686
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 5.421243093922 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 5.421243093922
11510 Prostaglandin Bx Exclusive 39306-29-1 Mixture of oligomers ✓ 30.350552486188 prostaglandin-bx PGBx PGBx free radicals antioxidants prostaglandins 30.350552486188
512031 Prostaglandin D2 EIA Kit - 2010-07-19 268.101938305709 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 268.101938305709
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 125.652167445813 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 125.652167445813
10006593 Prostaglandin D Synthase (hematopoietic-type; human recombinant) - ≥95% 2005-02-16 34.087328334649 prostaglandin-d-synthase-hematopoietic-type-human-recombinant Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators 34.087328334649
10009625 Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control - 2007-07-19 24.699454419889 prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control Hematopoietic-PGDS; H-PGDS western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli 24.699454419889
10004347 Prostaglandin D Synthase (hematopoietic-type; mouse recombinant) Exclusive - ≥85% ✓ 2008-06-05 33.098225905463 prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant H-PGDS; Hematopoietic-PGDS PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS 33.098225905463
10006595 Prostaglandin D Synthase Inhibitor Screening Assay Kit - 2005-08-31 47.598204419889 prostaglandin-d-synthase-inhibitor-screening-assay-kit PGDS Inhibitor Screening Assay Kit prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS 47.598204419889
10006788 Prostaglandin D Synthase (lipocalin-type; human recombinant) - ≥95% 2005-03-23 39.367700605103 prostaglandin-d-synthase-lipocalin-type-human-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 39.367700605103
10009741 Prostaglandin D Synthase (lipocalin type; human) Western Ready Control - 2007-04-30 6.126104972375 prostaglandin-d-synthase-lipocalin-type-human-western-ready-control L-PGDS; Lipocalin-PGDS GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS 6.126104972375
10006787 Prostaglandin D Synthase (lipocalin-type; mouse recombinant) - ≥95% 2005-03-23 41.216685082873 prostaglandin-d-synthase-lipocalin-type-mouse-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 41.216685082873
10010548 Prostaglandin D Synthase (lipocalin-type; rat recombinant) Exclusive - ≥95% ✓ 2008-07-01 38.236034849129 prostaglandin-d-synthase-lipocalin-type-rat-recombinant L-PGDS; Lipocalin-PGDS prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds 38.236034849129
14010 Prostaglandin E2 363-24-6 ≥99% 256.004151789883 prostaglandin-e2 PGE2; Dinoprostone PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 256.004151789883
514018 Prostaglandin E2 Affinity Purification Kit (20 ml) - 243.960254143646 prostaglandin-e2-affinity-purification-kit-20-ml PGE2 Affinity Purification Kit PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies 243.960254143646
500450 Prostaglandin E2 Affinity Purification Kit (4 ml) - 2010-07-28 191.640753749013 prostaglandin-e2-affinity-purification-kit-4-ml PGE2 PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies 191.640753749013
10581 Prostaglandin E2-d9 - ≥99% deuterated product 2010-09-16 95.288941068139 prostaglandin-e2-d9 PGE2-d9; Dinoprostone-d9 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards 95.288941068139
514010 Prostaglandin E2 EIA Kit - Monoclonal - 1746.832549807466 prostaglandin-e2-eia-kit-monoclonal PGE2 EIA Kit - Monoclonal; Prostaglandin E2 ELISA Kit - Monoclonal solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays PGE2 1746.832549807466
500141 Prostaglandin E2 Express EIA Kit - 491.032168508287 prostaglandin-e2-express-eia-kit PGE2 Express EIA Kit; Prostaglandin E2 Express ELISA Kit solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays 491.032168508287
500501 Prostaglandin E2 FPIA Kit - Green - 142.502231430325 prostaglandin-e2-fpia-kit-green PGE2 Fluorescence Polarization Immunoassay - Green kitrecommendation:pge2 metabolites EP1 EP2 EP3 EP4 prostaglandins immunoassays HTS fluorescent high-throughput kits screenings fluorescence fluorometric assays 142.502231430325
10384 Prostaglandin E2 isopropyl ester Exclusive 71845-66-4 ≥98% ✓ 2010-06-07 324.828397790054 prostaglandin-e2-isopropyl-ester PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic 324.828397790054
10007211 Prostaglandin E2 Lipid Maps MS Standard 363-24-6 >99% 2008-11-05 16.598158379374 prostaglandin-e2-lipid-maps-ms-standard Dinoprostone; PGE2 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 16.598158379374
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 25.421565377532 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 25.421565377532
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.713128453038 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.713128453038
10010498 Prostaglandin E Synthase (cytosolic) (human recombinant, inactive protein) - 22.3 kDa (His-tagged); 18 kDa (native) 2008-01-22 3.946563535911 prostaglandin-e-synthase-cytosolic-human-recombinant-inactive-protein Hsp90 Co-chaperone; p23; Telomerase-binding protein p23; cPGE Synthanse; cPGES cPGES cPGE synthases telomerase-binding proteins p23 Hsp90 cochaperone PGES cytosolic enzymes 3.946563535911
10009735 Prostaglandin E Synthase (cytosolic) Western Ready Control - 2007-04-02 10.446961325966 prostaglandin-e-synthase-cytosolic-western-ready-control Hsp 90 Co-chaperone; p23; cPGE Synthase; cPGES; Telomerase-binding protein p23 telomerase-binding protein p23 blotting blots western WB glutathione dependent enzymes pges 10.446961325966
10009746 PTEN (human recombinant) - ≥95% 2008-09-04 7.611226519336 pten-human-recombinant Phosphatase and Tensin Homology on Chromosome 10; TEP1; Phosphatidylinositol 3-phosphatase; MMAC1 proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged 7.611226519336
10009747 PTEN Western Ready Control - 2007-05-30 0E-12 pten-western-ready-control TEP1; MMAC1; Phosphatidylinositol 3-phosphatase; Phosphatase and Tensin Homology on Chromosome 10 western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology 0E-12
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 34.272707182320 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 34.272707182320
10009594 Pyocyanin 85-66-5 >98% 2007-07-12 32.295635359116 pyocyanin Pyocyanine; Sanazin; Sanasin Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis 32.295635359116
13294 Pyrrophenone 341973-06-6 ≥90% 2010-04-07 51.947504688529 pyrrophenone phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines 51.947504688529
10006734 QNZ 545380-34-5 >98% 2005-12-16 36.888639502762 qnz CAY10470 inhibits inhibitor inhibition NF kB NF-kB NF-.kappa.B nuclear factors transcription proinflammatory cytokines TNFa TNF.alpha. interleukins IL-1b IL-1.beta. IL-6 IL-8 activation Jurkat cells LPS lipopolysaccharides murine splenocytes in vivo edema carrageenin rat hind paw NF-kappaB nfkb nf-kb NF-.kappa.B 36.888639502762
10006045 (R)-Butaprost (free acid) - >98% 2004-11-09 20.071726519336 -r-butaprost-free-acid 15-deoxy-16R-hydroxy-17-cyclobutyl PGE1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1 PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers 20.071726519336
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.881973164956 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 256.881973164956
500380 Resolvin D1 EIA Kit New - 2012-01-13 192.779733898328 resolvin-d1-eia-kit RvD1 EIA ELISAs enzymes immunoassays kits measures measurements resolvins lipids mediators eicosapentaenoic acids EPAs docosahexaenoic DHA inflammation non-inflamed state oxygenation oxygenated 15-lipoxygenase 5 lipoxygenase 15-LO 5-LO 17(R)-RvD1 17(R) epimers aspirin-treatments configurations humans polymorphonuclear leukocytes PMNL transendothelial migrations acute aspirin-triggered murine mouse mice rat model peritonitis inhibition inhibits inhibitors adjuvant-induced arthritis antihyperalgesic effects prevents attenuates post-operative pains transient receptors potentials TRP channels TRPA1 TRPV3 TRP4 anti-nociceptives phagocytes ALX GPR32 insulin sensitivity leptins (db/db) pro-inflammatory macrophages adipose tissues 192.779733898328
10007279 Resolvin D2 Exclusive 810668-37-2 ≥95% ✓ 2010-06-25 147.394931742650 resolvin-d2 7(S),16(R),17(S)-Resolvin D2 EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis Docosahexaenoic Acid 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-(All-Z-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-Isomer Docosahexaenoic Acid 3,6,9,12,15,18-Isomer Docosahexaenoic Acid Dimer (All-Z Isomer) Docosahexaenoic Acid (All-Z Isomer) Acids Docosahexaenoic Docosahexaenoic Acids Acids Docosahexenoic Docosahexenoic Acids Docosahexaenoic Acid Docosahexaenoate 147.394931742650
13832 Resveratrol 3-O-D-Glucuronide 387372-17-0 ≥95% 2010-04-02 12.651933701657 resveratrol-3-o-d-glucuronide 1028964-58-0 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 12.651933701657
13900 Resveratrol-3-O-Sulfate 553662-69-4 ≥98% 2011-06-01 27.570370955011 resveratrol-3-o-sulfate polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans 27.570370955011
13833 Resveratrol 4'-O-D-Glucuronide 387372-20-5 ≥95% 2010-04-02 12.651933701657 resveratrol-4-o-d-glucuronide 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 12.651933701657
13616 (R)-Lisofylline 100324-81-0 ≥98% 2010-05-27 1.784944751381 -r-lisofylline (R)-LSF; (-)-Lisofylline pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma 1.784944751381
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% ✓ 2010-06-22 93.183756906077 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 93.183756906077
10011132 Rolipram 61413-54-5 ≥98% 2008-12-16 11.821048563680 rolipram ZK 62711; SB 95952 inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss 11.821048563680
13343 RSC-3388 337307-06-9 ≥95% 2010-02-15 11.178298950783 rsc-3388 cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis acrylamides 11.178298950783
10009227 (R)-SLV 319 656827-86-0 >98% 2007-09-05 0.216408839779 -r-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation 0.216408839779
13628 Salidroside 10338-51-9 ≥97% 2010-05-28 12.325948434623 salidroside Rhodioloside glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis Glucosides 12.325948434623
10951 Sampling Tubes with Indomethacin - 2011-06-01 0E-12 sampling-tubes-with-indomethacin spi-bio spibio COX inhibitors ex-vivo thromboxane B2 TXB2 PGs prostagandins cyclooxygenase anticoagulant sampling tubes blood metabolites 0E-12
13336 SB 225002 182498-32-4 ≥95% 2009-07-08 42.237320441988 sb-225002 CXCR2 IL-8RB IL-8 CXCL8 Gro-α CXCL1 inflammation chemokines neutrophils angiogenesis inhibitors colitis chemotaxis IL8 IL8RB Groα inhibition inhibits sb225002 42.237320441988
10010744 SC-51322 146032-79-3 >98% 2010-03-09 14.510596685082 sc-51322 SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos 14.510596685082
10010267 SC-514 354812-17-2 ≥98% 2009-08-07 37.142839779005 sc-514 SC514 SC 514 inhibitors inhibits inhibitions IκB kinase IkB IKK2 NF-κB NFκB IL-1β IL1β genes expressions IL-6 IL6 IL-8 IL8 COX-2 COX2 iNOS LPS smooth muscles cells TLR2 TNF astrocytes 37.142839779005
70655 SC-58125 162054-19-5 >98% 15.691049723756 sc-58125 selective inhibitors inhibits COX-2 cox2 pghs2 pghs-2 prostaglandin synthases synthase-2 sc58125 cyclooxygenases diaryl heterocycles time-dependent 15.691049723756
13617 (S)-Lisofylline Exclusive 100324-80-9 ≥98% ✓ 2010-05-27 1.493646408840 -s-lisofylline (S)-LSF; (+)-Lisofylline pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed 1.493646408840
10009226 (±)-SLV 319 Exclusive 362519-49-1 >98% ✓ 2007-01-16 21.822596685082 -slv-319 CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic 21.822596685082
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 192.178839779005 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 192.178839779005
13121 Sodium Butyrate 156-54-7 ≥95% 2009-07-31 79.349723756906 sodium-butyrate Butyric Acid (sodium salt) fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg 79.349723756906
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 26.704851647227 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 26.704851647227
10011669 Soluble Epoxide Hydrolase (human recombinant) - ≥95% 2008-07-02 23.122430939226 soluble-epoxide-hydrolase-human-recombinant EPHX2; Epoxide Hydrolase 2; sEH; Cytosolic Epoxide Hydrolase; CEH recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis 23.122430939226
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 22.916324432167 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions 22.916324432167
10011670 Soluble Epoxide Hydrolase (mouse recombinant) Exclusive - ≥95% ✓ 2008-07-01 5.371944751380 soluble-epoxide-hydrolase-mouse-recombinant sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278 5.371944751380
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 7.101390965226 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 7.101390965226
10010466 SP 600125 129-56-6 ≥98% 2009-01-07 11.958232044199 sp-600125 1PMV; Pyrazolanthrone; NSC 75890 c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 11.958232044199
10008012 SPD-304 Exclusive 869998-49-2 >98% ✓ 2006-08-07 19.841215469613 spd-304 TNF-.alpha. TNF.alpha. signal transduction inflammation small-molecule inhibitor cytokine apoptosis NF-kB AP-1 inhibitor antagonist SPD304 SPD 304 CAY10500 CAY 10500 SPD00000304 SPD 00000304 19.841215469613
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 37.411236516705 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 37.411236516705
10348 Sphingosine Kinase 1 (human recombinant) - ≥90% by SDS-PAGE 2011-04-12 43.972817679558 sphingosine-kinase-1-human-recombinant SPHK1; SK1 sphingosines phosphates ceramides apoptosis acids cells death kinases sphingomyelin growth calcium 43.972817679558
10012201 Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive - ✓ 2008-06-06 7.574102209944 sphingosine-kinase-1-polyclonal-fitc-antibody SPHK 1 SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting 7.574102209944
10009237 Sphingosine Kinase 2 (human recombinant) - >80% by SDS-PAGE 2007-01-18 30.875382794001 sphingosine-kinase-2-human-recombinant SPHK 2; SK2 signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases 30.875382794001
10009563 sPLA2 (human recombinant Type V) - >95% 2007-01-16 49.810227133210 spla2-human-recombinant-type-v Secretory Phospholipase A2 (Group V); gVPLA2 proteins binding enzymes secretory phospholipases recombinant E. coli catalyzes hydrolysis fatty acids sn-2 glycerophospholipids isoforms arachidonic mobilization macrophages mast cells golgi apparatus nuclear envelope plasma membranes murine bone marrow-derived rat mouse heart lung placenta spleen P388D1 electrophoresis coomassie staining 49.810227133210
10011382 sPLA2 (human Type IIA) Western Ready Control Exclusive - ✓ 2008-03-17 32.325840568271 spla2-human-type-iia-western-ready-control Secretory Phospholipase A2 (human Type IIA); sPLA2 (human synovial) WB western blots blotting immunoblotting 32.325840568271
10009739 sPLA2 (human type V) Western Ready Control - 2007-05-25 17.854162062615 spla2-human-type-v-western-ready-control sPLA2 (group V); gVPLA2 western blotting WB controls antibodies antisera antiserum phospholipases sPLA2s group secretory monoclonal 17.854162062615
10922 SR 1001 - ≥98% 2011-06-28 82.680272954083 sr-1001 inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 82.680272954083
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 71.692483118478 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 71.692483118478
10009022 (S)-SLV 319 Exclusive 464213-10-3 >98% ✓ 2007-08-16 0.216408839779 -s-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands 0.216408839779
10846 STAT1α/β Polyclonal Antibody - 2011-05-31 0E-12 stat1-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcriptions factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT1alpha/beta STAT1 alpha/beta signaling signalling STAT 1 STAT-1 STAT1a/b 0E-12
10847 STAT2 Polyclonal Antibody - 2011-05-31 0E-12 stat2-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-2 STAT 2 signaling signalling 0E-12
10861 STAT3 (Phospho-Tyr705) Polyclonal Antibody - 2011-05-31 0E-12 stat3-phospho-tyr705-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-3 STAT 3 signaling signalling 0E-12
10856 STAT5β Polyclonal Antibody - 2011-05-31 0E-12 stat5-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT5beta STAT5 signaling signalling STAT 5 STAT-5 0E-12
10931 STAT6 Polyclonal Antibody - 2011-07-13 0E-12 stat6-polyclonal-antibody Signal Transducers and Activators of Transcription 6; IL-4 STAT transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-6 STAT 6 signaling signalling 0E-12
10007207 tetranor-12(S)-HETE 121842-79-3 ≥98% 2005-12-07 36.477127071823 tetranor-12-s-hete neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology 36.477127071823
13369 tetranor-PGAM Exclusive New 52510-53-9 ≥98% ✓ 2011-12-15 89.640463671084 tetranor-pgam tetranor-Prostaglandin A Metabolite tetranor-PGEM PGE2 urine metabolites prostaglandins E2 biomarkers inflammation diseases therapeutic metabolism biosynthesis tetranor PGAM tetranorPGAM PGA-M PGE-M 89.640463671084
12850 tetranor-PGDM Exclusive - ≥90% ✓ 2008-04-08 87.929546410956 tetranor-pgdm tetranor-PGD Metabolite metabolites urinary PGD2 prostaglandins D2 urine PGD-M 87.929546410956
501001 tetranor-PGDM EIA Kit Exclusive - ✓ 2009-06-15 76.698017488723 tetranor-pgdm-eia-kit tetranor-Prostaglandin D Metabolite ELISA Kit solid plates prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays PGD-M 76.698017488723
13564 tetranor-PGDM lactone Exclusive New - ≥90% ✓ 2012-01-19 136.243374969973 tetranor-pgdm-lactone tetranor-Prostaglandin D Metabolite lactone urine PGD2 prostaglandins D2 tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitor platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M 136.243374969973
10522 Thapsigargin New 67526-95-8 ≥97% 2011-09-23 105.820852192546 thapsigargin calcium, ATPases, sarco/endoplasmic calcium ATPases SERCAs cells signaling activation histamine cancers tumorigenesis inflammation reticula sarcoplasmic endoplasmic 105.820852192546
70480 Tolfenamic Acid 13710-19-5 >99% 5.953802946592 tolfenamic-acid Clotam cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits calcium influx 5.953802946592
11111 Toll-Like Receptor 10 Monoclonal Antibody (Clone 3C10C5) New - 2011-11-18 6.999414029801 toll-like-receptor-10-monoclonal-antibody-clone-3c10c5 TLR10; CD290 TLRs innate immune systems transmembrane proteins cells patterns recognition receptors PRRs pathogen-associated molecular PAMPs signaling TIR domains Flow cytometry FC TLR10 TLR-10 6.999414029801
13582 Toll-Like Receptor 1 Polyclonal Antibody - 2009-10-10 0.794375973934 toll-like-receptor-1-polyclonal-antibody TLR1 antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins 0.794375973934
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 68.693709550118 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 68.693709550118
11120 TPPU Exclusive New 1222780-33-7 ≥98% ✓ 2011-10-26 6.444971864129 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 6.444971864129
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 76.754683855126 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 76.754683855126
10855 TRAF2 Monoclonal Antibody (Clone 33A1293) - 2011-05-06 0E-12 traf2-monoclonal-antibody-clone-33a1293 TRAF 2 TRAF-2 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 0E-12
10872 TRAF3 Polyclonal Antibody - 2011-05-26 1.445104972375 traf3-polyclonal-antibody TRAF 3 TRAF-3 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.445104972375
10873 TRAF5 Monoclonal Antibody (Clone 55A219) - 2011-05-26 1.445104972375 traf5-monoclonal-antibody-clone-55a219 TRAF 5 TRAF-5 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.445104972375
10894 TRAF6BP Polyclonal Antibody - 2011-05-26 1.445104972375 traf6bp-polyclonal-antibody TRAF6 Binding Protein; TAX1-binding protein; T6BP; TAX1BP1 TRAF 6BP TRAF-6BP WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.445104972375
10874 TRAF6 Polyclonal Antibody - 2011-05-26 1.445104972375 traf6-polyclonal-antibody TNF Receptor-Associated Factor 6 TRAF 6 TRAF-6 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.445104972375
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 83.935779005525 tranilast Tranpro; SB 252218; Rizaben; MK 341; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 83.935779005525
70675 trans-Resveratrol 501-36-0 >98% 96.100285851549 trans-resveratrol (E)-Resveratrol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors 96.100285851549
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 18.699378453038 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 18.699378453038
10188 trans-trismethoxy Resveratrol 22255-22-7 >98% 2004-03-03 20.739167020824 trans-trismethoxy-resveratrol (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy AHR antagonists aryl hydrocarbon receptors 20.739167020824
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 17.114249539594 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 17.114249539594
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.160220994475 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.160220994475
10007457 URB602 565460-15-3 >98% 2005-09-06 40.770787292817 urb602 monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic 40.770787292817
10812 Vaspin (human) Monoclonal Antibody (Clone VP63) - 2011-06-27 4.667817679558 vaspin-human-monoclonal-antibody-clone-vp63 OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin 4.667817679558
10010519 Vialinin A 858134-23-3 ≥98% 2008-07-25 31.268950276243 vialinin-a Terrestrin A .beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant 31.268950276243
10009023 (+)WIN 55212-2 (mesylate) 131543-23-2 >98% 2006-10-05 47.709641060716 -win-55212-2-mesylate WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic 47.709641060716
13246 YM-58483 223499-30-7 ≥98% 2009-11-16 1.983563535911 ym-58483 BTP 2 calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT 1.983563535911
13665 YS121 Exclusive 916482-17-2 ≥98% ✓ 2010-04-02 20.004903314917 ys121 Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 20.004903314917
13271 ZLJ-6 Exclusive 1051931-39-5 ≥98% ✓ 2009-06-17 38.591892265193 zlj-6 inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 38.591892265193
10008652 (±)-α-CMBHC 7083-09-2 ≥98% 2006-10-18 4.903725335437 -cmbhc vitamin E tocopherals tocotrienols a-CEHC alpha-CEHC .alpha.-CEHC a-tocopherol alpha-tocopherol .alpha.-tocopherol metabolites g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienols HepG2 cells a-CMBHC alpha-CMBHC .alpha.-CMBHC a-CMHHC alpha-CMHHC .alpha.-CMHHC rac rifmpicin CYP3A cytochromes P450s w-oxidation omega-oxidation .omega.-oxidation b-oxidation beta-oxidation .beta.-oxidation 4.903725335437
10008377 α-Tocotrienol 58864-81-6 >98% 2006-10-18 20.174736313410 -tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 toxicity HT4 cytosolic glutamatec-Src kinases 12-lipoxygenases 12-LOs 20.174736313410
10008494 γ-Tocotrienol 14101-61-2 >98% 2006-10-20 15.476307550644 -tocotrienol g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans hypertensive hypertension systolic blood pressures NOS nitric oxides synthases vessels malignant sympathoadrenal +SA mouse murine rats mammary epithelial cells 15.476307550644
10008513 δ-Tocotrienol 25612-59-3 >98% 2006-10-20 11.330405156537 -tocotrienol d-Tocotrienol delta-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neurons neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 cytotoxicity inhibits inhibitors inhibition HAECs U937 monocytic cells VCAM-1 11.330405156537
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?